Book now

Research collaboration awarded TxSCO recognition

HCMRI researcher & Principal Investigator honored as recipient of the 2023 Texas Society of Clinical Oncology (TxSCO) research abstract competition with award at annual TxSCO conference for research on Experimental Treatment of Metastatic Breast Cancer Progression in the Thoracic Cavity performed in collaboration with University of Texas Health Science Center at Houston | UTHealth-Houston colleagues. TxSCO: https://www.accc-cancer.org/state-societies/Texas/about

Specialties & services

We offer a wide range of clinical research services at affordable prices
In addition to leading research, we offer a range of services including global clinical research, drug discovery, and medical device development, all designed to help our partner-collaborators achieve their goals and improve the cancer burden amongst the Hispanic population. HCMRI minimizes the disruption in the personal lives of cancer patients who must travel to various centers to gain access to a clinical trial by being strategically engaged in clinical and translational research that benefits the Hispanic community.

Vascular

Vascular & metastatic cancer research infiltrating distant organ sites
Learn more

Endocrinology & Breast

Breast and Thyroid cancer clinical studies
Learn more

Lab services

Our Prinicpal Investigators (PI's) have multiple analytical services and biometric quantitative technologies to assist with bench-to-bedside analysis and collaborative clinical research.
Learn more

Pediatrics

Childhood cancer studies, childhood Acute Myeloid Leukemia (AML), childhood Acute Lymphoblastic Leukemia (ALL)
Learn more

Dermatology

Skin cancer clinical research, Melanoma studies
Learn more

Head & Neck, Thoracic, Rheumatology

Head and Neck, Thoracic, auto-immune & rheumatoid arthritis clinical research studies
Learn more
Experience
Society of Clinical Research Association (SoCRA) certified-Principal Investigators and clinical research coordinators with CITI training, continued ICH/GCP/CFR education, and internationally-accepted standard of knowledge, education, experience as Certified Clinical Research Professionals (CCRP®s) in the clinical research community. We have over 16 years of bench to bedside research experience & metabolomics/ proteomics/ genomics post-doctoral training paired with prior clinical research experience at leading biomedical institutions (Baylor College of Medicine) and global cancer research hospitals (University of Texas MD Anderson Cancer Center) to advance clinical translational and immunotherapeutic discoveries that impact cancer research. Learn more https://www.socra.org/
Innovation
International research collaboration between investigators across 3 countries in North America (radio-oncologist & HCMRI co-PI) publication of solitary plasmacytoma, malignancy characterized by monoclonal proliferation of abnormal plasma cells in bone tissue or extramedullary, and absence of multiple myeloma-defining clinical characteristics (bone lesions, end-organ damage, plasmacytosis, anemia, hypercalcemia). Solitary extramedullary plasmacytomas occur in head & neck-either surgical approach or localized external beam radiotherapy as definitive treatment. EBRT has therapeutic effects in SEP management as noninvasive modality. Learn morehttps://pubmed.ncbi.nlm.nih.gov/37288179/
Diversity
Diversity-oriented patient recruitment focused on the Hispanic community with integration of patient-advocates and clinical research staff. We believe that patients who are eligible to be in a clinical research study should have the opportunity to participate, and that ethnic, racial or financial status should not be a limiting factor. HCMRI provides the same opportunities that major institutions offer to patients who are seen at community clinics in a setting close to home. Currently our adult and pediatric partner clinics are located in the Rio Grande Valley, San Antonio, Houston/Gulf Coast, and east Texas communities.